Taking account of future technology in cost effectiveness analysis

Joshua A Salomon; Milton C Weinstein; Sue J Goldie

doi:10.1136/bmj.329.7468.733

Taking account of future technology in cost effectiveness analysis

BMJ. 2004 Sep 25;329(7468):733-6. doi: 10.1136/bmj.329.7468.733.

Authors

Joshua A Salomon¹, Milton C Weinstein, Sue J Goldie

Affiliation

¹ Department of Population and International Health, Harvard School of Public Health, Harvard Center for Population and Development Studies, 9 Bow Street, Cambridge MA 02138, USA. jsalomon@hsph.harvard.edu

Abstract

Economic evaluations in health and medicine usually ignore the possibility of future advances in treatment. But when technological innovation is rapid such considerations can have major implications

Publication types

Review

MeSH terms

Cost-Benefit Analysis
Forecasting
Hepatitis C / economics
Hepatitis C / therapy*
Humans
Markov Chains
Medical Laboratory Science / economics*
Medical Laboratory Science / trends
Quality-Adjusted Life Years
Resource Allocation
Retrospective Studies